EspAddText
EspRemoveText
|
Joint statement on preventing and resolving ethical conflicts involving health care providers and persons receiving care
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
Principles concerning physician information
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
The future of medicine
|
Policy document
|
2017
|
EspAddText
EspRemoveText
|
Guidelines for CMA's activities and relationships with other parties
|
Policy document
|
2018
|
EspAddText
EspRemoveText
|
Medical professionalism (Update 2005)
|
Policy document
|
2018
|
EspAddText
EspRemoveText
|
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
|
Parliamentary submission
|
2012
|
EspAddText
EspRemoveText
|
Putting Patients First : Comments on Bill C 6 (Personal Information Protection and Electronic Documents Act) : Submission to the Senate Standing Committee on Social Affairs, Science and Technology
|
Parliamentary submission
|
2019
|
EspAddText
EspRemoveText
|
Listening to our Patient's Concerns : Comments on Bill C 54 (Personal Information Protection and Electronic Document Act) : Submission to the House of Commons Standing Committee on Industry
|
Parliamentary submission
|
2019
|
EspAddText
EspRemoveText
|
Caring in a Crisis: The Ethical Obligations of Physicians and Society During a Pandemic
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
Cannabis for Medical Purposes
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
Medication use and seniors (Update 2017)
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
|
Parliamentary submission
|
2012
|
EspAddText
EspRemoveText
|
The evolving professional relationship between Canadian physicians and our health care system: Where do we stand?
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
|
Parliamentary submission
|
2012
|
EspAddText
EspRemoveText
|
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
|
Parliamentary submission
|
2012
|
EspAddText
EspRemoveText
|
Corporate privacy policy respecting the collection, use and disclosure of personal information (Update 2012)
|
Policy document
|
2017
|
EspAddText
EspRemoveText
|
Vision for e-Prescribing: a joint statement by the Canadian Medical Association and the Canadian Pharmacists Association
|
Policy document
|
2019
|
EspAddText
EspRemoveText
|
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
|
Parliamentary submission
|
2013
|
EspAddText
EspRemoveText
|
Position statement on prescription drug shortages in Canada
|
Policy document
|
2017
|
EspAddText
EspRemoveText
|
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
|
Parliamentary submission
|
2013
|